PwC's Next in Health

The One Big Beautiful Bill: What It Means for the Future of U.S. Healthcare

Strategic Dealmaking in Health: Navigating Midyear Trends in 2025

Taking a closer look at the Most Favored Nation Pricing Executive Order

Navigating the FDA disruption: 4 key actions for pharma

Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma

Navigating Healthcare’s Next Chapter Under the Trump Administration

Next in Pharma: The 2025 Outlook—The Future is Now

Next in Health: The 2025 Outlook for Health Services

Health Industries: U.S. Deals Outlook for 2025 and Beyond

PwC’s 2024 US Healthcare Climate Survey

PwC's U.S. Healthcare Consumer Insights and Engagement Survey

Next in medtech: Unlocking future growth in 3 strategic steps

Election Impact: What to expect for the Health Industry

Boardroom essentials: Securing a seat on an emerging company board

PwC's 2025 Medical cost trend report reveals rising healthcare costs

The importance of physician enablement to our health ecosystem

How emerging companies are navigating growth in the health industry

2024 Outlook: Healthcare's big squeeze and the way out

Reinventing for returns: what's next in pharma?

The year in Deals: Preparing for 2024

Transforming healthcare collaboration through the power of health ecospheres

Harnessing data insights: Revolutionizing healthcare and costs for patients with complex chronic conditions

The secret to attracting and retaining healthcare consumers

Transforming Ukraine’s healthcare infrastructure for a sustainable future

Future-proofing behavioral health care: Innovations to ensure no one is left behind

Key strategies for global pharma companies to reduce risk and drive growth in the China market

How technology is helping to transform behavioral and mental health care across the globe

The potential of GenAI in health care

What to know about using GenAI in the pharma and life sciences industry

The SCAN Group reinvents coverage and care for the seniors

Transforming consumer and patient engagement in life sciences

Key findings from PwC's medical trend cost report, Behind the Numbers 2024

The year in Deals 2023 and beyond

Innovations in oncology

Better Care for the Elderly

How the finance function is helping to build the future of healthcare

Revolutionizing healthcare experiences through immersive technology

What pharma stakeholders need to know about the Drug Supply Chain Security Act (DSCSA)

Enabling chat platforms to connect the the prescribing physicians to the manufacturers of the medications

How employers and employees can get the most out of health benefits

How healthcare organizations can be more resilient and prepared for the next pandemic

The future of vaccines

How payers are mastering advanced analytics to enhance patient outcomes

Cardinal Health’s vision for precision healthcare in the pharmaceutical and life sciences industry

Leveraging digital technology to improve staffing and scheduling in healthcare organizations

The value of integrating ESG strategy into business strategy for health organizations

How pharmaceutical and life sciences organizations can create an "innovation engine" to drive value in the market

What drives and reduces disparities in health care

The journey to a next generation data-enabled healthcare delivery model

How PwC's digital products are helping to improve quality, equity, and affordability in health care